Aligned Genetics, Inc. (KOSDAQ:238120)
South Korea
· Delayed Price · Currency is KRW 3,000.00
+85.00 (2.92%)
At close: Apr 1, 2025, 3:30 PM KST
Aligned Genetics Revenue
In the year 2024, Aligned Genetics had annual revenue of 15.78B KRW with 3.70% growth. Aligned Genetics had revenue of 5.61B in the quarter ending December 31, 2024, with 16.11% growth.
Revenue
15.78B
Revenue Growth
+3.70%
P/S Ratio
2.73
Revenue / Employee
n/a
Employees
66
Market Cap
43.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.78B | 562.88M | 3.70% |
| Dec 31, 2023 | 15.21B | 1.46B | 10.63% |
| Dec 31, 2022 | 13.75B | 1.99B | 16.92% |
| Dec 31, 2021 | 11.76B | 3.80B | 47.82% |
| Dec 31, 2020 | 7.96B | 163.45M | 2.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| Hanwha Aerospace | 11.24T |